siemens healthineers ag - SMMNY

SMMNY

Close Chg Chg %
28.06 -0.02 -0.07%

Closed Market

28.04

-0.02 (0.07%)

Volume: 52.73K

Last Updated:

Dec 13, 2024, 3:59 PM EDT

Company Overview: siemens healthineers ag - SMMNY

SMMNY Key Data

Open

$28.24

Day Range

27.97 - 28.28

52 Week Range

25.54 - 31.73

Market Cap

$63.08B

Shares Outstanding

2.24B

Public Float

N/A

Beta

0.96

Rev. Per Employee

N/A

P/E Ratio

29.93

EPS

$0.94

Yield

107.19%

Dividend

$0.30

EX-DIVIDEND DATE

Apr 19, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

134.62K

 

SMMNY Performance

1 Week
 
3.28%
 
1 Month
 
6.49%
 
3 Months
 
2.04%
 
1 Year
 
-2.99%
 
5 Years
 
19.52%
 

SMMNY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 18
Full Ratings ➔

About siemens healthineers ag - SMMNY

Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. It operates through the following business segments: Imaging, Diagnotics, Varian and Advanced Therapies. The Imaging segment provides imaging products, services, and solutions as well as digital offerings. The Diagnostics segment provides a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Varian segment provides innovative, multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments in hospitals and clinics globally. The Advanced Therapies segment consist of integrated products, services and solutions across multiple clinical fields used in the treatment of diseases. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Forchheim, Germany.

SMMNY At a Glance

Siemens Healthineers AG
Siemensstr. 3
Forchheim, Bayern (Bavaria) 91301
Phone 49-9131-84-3385 Revenue 24.24B
Industry Medical Specialties Net Income 2.11B
Sector Health Technology 2024 Sales Growth 4.827%
Fiscal Year-end 09 / 2025 Employees 72,000
View SEC Filings

SMMNY Valuation

P/E Current 29.932
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 31.929
Price to Sales Ratio 2.786
Price to Book Ratio 3.312
Price to Cash Flow Ratio 25.233
Enterprise Value to EBITDA 16.864
Enterprise Value to Sales 3.411
Total Debt to Enterprise Value 0.219

SMMNY Efficiency

Revenue/Employee 336,675.775
Income Per Employee 29,236.88
Receivables Turnover 3.015
Total Asset Turnover 0.481

SMMNY Liquidity

Current Ratio 1.248
Quick Ratio 0.887
Cash Ratio 0.232

SMMNY Profitability

Gross Margin 37.866
Operating Margin 14.757
Pretax Margin 11.291
Net Margin 8.684
Return on Assets 4.176
Return on Equity 10.671
Return on Total Capital 5.482
Return on Invested Capital 6.242

SMMNY Capital Structure

Total Debt to Total Equity 89.065
Total Debt to Total Capital 47.108
Total Debt to Total Assets 35.195
Long-Term Debt to Equity 73.933
Long-Term Debt to Total Capital 39.104
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Siemens Healthineers Ag - SMMNY

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
21.51B 23.48B 23.12B 24.24B
Sales Growth
+32.87% +9.16% -1.50% +4.83%
Cost of Goods Sold (COGS) incl D&A
13.20B 14.68B 14.90B 15.06B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.24B 1.45B 1.66B 1.33B
Depreciation
750.45M 810.86M 863.96M 792.38M
Amortization of Intangibles
491.14M 641.12M 796.77M 533.31M
COGS Growth
+32.79% +11.21% +1.52% +1.07%
Gross Income
8.31B 8.80B 8.22B 9.18B
Gross Income Growth
+33.01% +5.90% -6.53% +11.63%
Gross Profit Margin
+38.63% +37.47% +35.56% +37.87%
2021 2022 2023 2024 5-year trend
SG&A Expense
4.99B 5.48B 5.62B 5.60B
Research & Development
1.85B 1.93B 1.99B 2.08B
Other SG&A
3.14B 3.55B 3.63B 3.52B
SGA Growth
+25.91% +9.93% +2.47% -0.32%
Other Operating Expense
- - - -
-
Unusual Expense
215.10M 129.74M 217.59M 467.19M
EBIT after Unusual Expense
3.10B 3.18B 2.38B 3.11B
Non Operating Income/Expense
(138.62M) (30.27M) (16.00M) 143.08M
Non-Operating Interest Income
39.43M 51.89M 90.66M 128.99M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
99.18M 127.57M 315.72M 515.97M
Interest Expense Growth
+16.59% +28.63% +147.48% +63.43%
Gross Interest Expense
99.18M 127.57M 315.72M 515.97M
Interest Capitalized
- - - -
-
Pretax Income
2.87B 3.03B 2.05B 2.74B
Pretax Income Growth
+31.22% +5.57% -32.12% +33.30%
Pretax Margin
+13.32% +12.89% +8.88% +11.29%
Income Tax
786.30M 806.53M 429.85M 611.35M
Income Tax - Current - Domestic
890.26M 1.09B 712.50M 832.48M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(103.96M) (287.58M) (282.65M) (221.13M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.09B 2.22B 1.63B 2.12B
Minority Interest Expense
21.51M 18.38M 17.07M 18.43M
Net Income
2.06B 2.20B 1.61B 2.11B
Net Income Growth
+30.67% +6.71% -26.92% +30.79%
Net Margin Growth
+9.60% +9.38% +6.96% +8.68%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.06B 2.20B 1.61B 2.11B
Preferred Dividends
- - - -
-
Net Income Available to Common
2.06B 2.20B 1.61B 2.11B
EPS (Basic)
0.9383 0.9812 0.7189 0.9413
EPS (Basic) Growth
+19.04% +4.57% -26.73% +30.94%
Basic Shares Outstanding
2.20B 2.25B 2.24B 2.24B
EPS (Diluted)
0.935 0.9769 0.7163 0.9369
EPS (Diluted) Growth
+18.88% +4.48% -26.68% +30.80%
Diluted Shares Outstanding
2.21B 2.26B 2.25B 2.25B
EBITDA
4.56B 4.76B 4.26B 4.90B
EBITDA Growth
+42.69% +4.49% -10.52% +15.00%
EBITDA Margin
+21.20% +20.30% +18.44% +20.23%

Snapshot

Average Recommendation BUY Average Target Price 31.637
Number of Ratings 18 Current Quarters Estimate 0.257
FY Report Date 12 / 2024 Current Year's Estimate 1.303
Last Quarter’s Earnings 0.36 Median PE on CY Estimate N/A
Year Ago Earnings 1.197 Next Fiscal Year Estimate 1.483
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 17 18
Mean Estimate 0.26 0.32 1.30 1.48
High Estimates 0.26 0.39 1.41 1.63
Low Estimate 0.25 0.30 1.26 1.44
Coefficient of Variance 2.73 14.55 3.03 3.00

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 13 13 13
OVERWEIGHT 2 3 3
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Siemens Healthineers Ag in the News